Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × Ethanol × Clear all

Phase

Status

Sponsor Class

OTHER 40 NIH 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 848 Carboplatin 794 Paclitaxel 782 Gemcitabine 652 Cisplatin 632 Docetaxel 589 Bevacizumab 510 Pemetrexed 410 Cyclophosphamide 402 Nivolumab 395 Capecitabine 380 Fluorouracil 333 Dexamethasone 327 Rituximab 318 Oxaliplatin 283 Injections 282 atezolizumab 251 Trastuzumab 245 Cetuximab 231 Leucovorin 230 Irinotecan 216 Prednisone 214 130-nm albumin-bound paclitaxel 213 Doxorubicin 210 Ipilimumab 187 Lenalidomide 186 Fulvestrant 180 fludarabine 179 durvalumab 171 venetoclax 165

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01698918 2023-05-03

BOLERO-4

Novartis

Phase 2 Completed

202 enrolled 19 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡